For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Oncolytics Biotech, Inc (NASDAQ: ONCY) closed the day trading at $0.94 down -5.70% from the previous closing price of $1.0. In other words, the price has decreased by -$5.70 from its previous closing price. On the day, 0.9 million shares were traded. ONCY stock price reached its highest trading level at $1.0014 during the session, while it also had its lowest trading level at $0.93.
Ratios:
For a better understanding of ONCY, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.84 and its Current Ratio is at 1.84. In the meantime, Its Debt-to-Equity ratio is 7.50 whereas as Long-Term Debt/Eq ratio is at 5.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Lake Street on August 13, 2025, initiated with a Buy rating and assigned the stock a target price of $7. On October 06, 2022, Maxim Group started tracking the stock assigning a Buy rating and target price of $3. On February 17, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $15.H.C. Wainwright initiated its Buy rating on February 17, 2021, with a $15 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ONCY now has a Market Capitalization of 99777600 and an Enterprise Value of 88260600.
Stock Price History:
The Beta on a monthly basis for ONCY is 0.88, which has changed by 0.06818187 over the last 52 weeks, in comparison to a change of 0.12607694 over the same period for the S&P500. Over the past 52 weeks, ONCY has reached a high of $1.51, while it has fallen to a 52-week low of $0.33. The 50-Day Moving Average of the stock is -19.19%, while the 200-Day Moving Average is calculated to be 8.01%.
Shares Statistics:
Over the past 3-months, ONCY traded about 1.05M shares per day on average, while over the past 10 days, ONCY traded about 733250 shares per day. A total of 103.64M shares are outstanding, with a floating share count of 98.63M. Insiders hold about 1.72% of the company’s shares, while institutions hold 2.81% stake in the company. Shares short for ONCY as of 1763078400 were 3330261 with a Short Ratio of 3.16, compared to 1760486400 on 3210176. Therefore, it implies a Short% of Shares Outstanding of 3330261 and a Short% of Float of 3.2399999999999998.
Earnings Estimates
. The current rating of Oncolytics Biotech, Inc (ONCY) reflects the combined expertise of 4.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.06 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.29 and -$0.41 for the fiscal current year, implying an average EPS of -$0.36. EPS for the following year is -$0.34, with 5.0 analysts recommending between -$0.2 and -$0.53.
